FDA Adds Boxed Warning for Prolia in Advanced CKD Due to Severe Risk Of Hypocalcemia

FDA Adds Boxed Warning for Prolia in Advanced CKD Due to Severe Risk Of Hypocalcemia

The U.S. Food and Drug Administration (FDA) has issued a Drug Safety Communication regarding Prolia (denosumab), an osteoporosis medication. Following…